文献速递银屑病与炎症性皮肤病

银屑病合并代谢综合征与非钙化冠状动脉负荷相关

Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: An observational cohort study.
PubMed 文献 · J Am Acad Dermatol · 2021-02-03

该横断面研究纳入260例接受冠状动脉CT血管造影的银屑病患者,按国际糖尿病联盟标准定义代谢综合征。31%患者合并代谢综合征,其非钙化冠状动脉负荷及高危斑块更高;校正Framingham风险评分等后,代谢综合征及其腰围、甘油三酯、血压、空腹血糖因素均与非钙化冠状动脉负荷独立相关。

要点

  • 银屑病患者中代谢综合征患病率较高,应主动筛查。
  • 代谢综合征及其各组分与非钙化冠状动脉负荷独立相关。
  • 控制血压与腰围或有助于降低银屑病心血管风险。

核心结论

  • 在银屑病患者中,合并代谢综合征者心血管病危险因素、系统性炎症及非钙化冠状动脉负荷更高。
  • 应提高银屑病患者对代谢综合征的认知,以降低其升高的心血管疾病风险。

研究设计与样本

  • 横断面观察性队列研究,纳入260例接受冠状动脉CT血管造影特征分析的银屑病患者。
  • 代谢综合征按国际糖尿病联盟(IDF)统一标准定义。

主要发现

  • 260例参与者中80例(31%)合并代谢综合征。
  • 代谢综合征组心血管代谢疾病负担、系统性炎症、非钙化冠状动脉负荷及高危冠状动脉斑块均更高。
  • 校正所有其他代谢综合征因素后,血压与腰围仍与非钙化冠状动脉负荷显著相关。

关键数值与推荐

  • 代谢综合征定义采用国际糖尿病联盟(IDF)统一标准。
  • 代谢综合征组占31%(80/260)。

临床怎么用

  • 对银屑病患者应筛查代谢综合征组分,尤其是腰围、血压、甘油三酯和空腹血糖。
  • 可将代谢综合征作为银屑病患者早期冠状动脉病变风险评估的参考因素。

局限性

  • 观察性研究,对混杂因素的控制能力有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is associated with a heightened risk of cardiovascular disease and higher prevalence of metabolic syndrome. OBJECTIVE: Investigate the effect of metabolic syndrome and its factors on early coronary artery disease assessed as noncalcified coronary burden by coronary computed tomography angiography in psoriasis. METHODS: This cross-sectional study consisted of 260 participants with psoriasis and coronary computed tomography angiography characterization. Metabolic syndrome was defined according to the harmonized International Diabetes Federation criteria. RESULTS: Of the 260 participants, 80 had metabolic syndrome (31%). The metabolic syndrome group had a higher burden of cardiometabolic disease, systemic inflammation, noncalcified coronary burden, and high-risk coronary plaque. After adjusting for Framingham risk score, lipid-lowering therapy, and biologic use, metabolic syndrome (β = .31; P < .001) and its individual factors of waist circumference (β = .33; P < .001), triglyceride levels (β = .17; P = .005), blood pressure (β = .18; P = .005), and fasting glucose (β = .17; P = .009) were significantly associated with noncalcified coronary burden. After adjusting for all other metabolic syndrome factors, blood pressure and waist circumference remained significantly associated with noncalcified coronary burden. LIMITATIONS: Observational nature with limited ability to control for confounders. CONCLUSIONS: In psoriasis, individuals with metabolic syndrome had more cardiovascular disease risk factors, systemic inflammation, and noncalcified coronary burden. Efforts to increase metabolic syndrome awareness in psoriasis should be undertaken to reduce the heightened cardiovascular disease risk.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Teklu M, Zhou W, Kapoor P, et al. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: An observational cohort study. J Am Acad Dermatol. 2021. PMID: 33383084. doi:10.1016/j.jaad.2020.12.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。